SCHEMBL6880476

SCHEMBL6880476

CC1CC(=O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12327529 1.00
SCHEMBL23371688 1.00
SCHEMBL25594422 0.91 PNMT (0.35)
Tert-Butyl Formate SCHEMBL27992301 0.79 TDP1 (0.45)
SCHEMBL10261526 0.76
SCHEMBL10261945 0.76
SCHEMBL1360201 0.76
Hydrochloric Acid SCHEMBL22999867 0.74
Hydrochloric Acid SCHEMBL4510205 0.74
Hydrochloric Acid SCHEMBL9951227 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012092168-A1 FUSED 6,5 BICYCLIC RING SYSTEM P2 LIGANDS, AND METHODS FOR TREATING HIV PURDUE RESEARCH FOUNDATION (US) 2012-07-05 WO claimed
WO-2012092188-A1 HYDROGEN BOND FORMING P1 LIGANDS AND METHODS FOR TREATING HIV GHOSH ARUN K (US) 2012-07-05 WO claimed
CN-109073940-B Liquid crystal dimming member, light-transmitting conductive film, and liquid crystal dimming element 日东电工株式会社 2022-03-08 CN disclosed
CN-106716182-B Polymerizable polysiloxane with hydrophilic substituent 爱尔康公司 2020-06-12 CN disclosed
CN-108289893-A Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2018-07-17 CN disclosed
CN-107531691-A Treat the derivative and method of hepatitis B infection 诺维拉治疗公司 2018-01-02 CN disclosed
US-20170137405-A1 COMPOUNDS FOR THE TREATMENT OF HIV GILEAD SCIENCES, INC. 2017-05-18 US disclosed
US-9540343-B2 Compounds for the treatment of HIV GILEAD SCIENCES, INC. (US) 2017-01-10 US disclosed
US-9499558-B2 Compounds and methods for treating HIV PURDUE RESEARCH FOUNDATION (US) 2016-11-22 US disclosed
US-20150225414-A1 COMPOUNDS AND METHODS FOR TREATING HIV NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-08-13 US disclosed
US-9024038-B2 Compunds and methods for treating HIV PURDUE RESEARCH FOUNDATION (US) 2015-05-05 US disclosed
US-8546442-B2 Pyrazolopiperidine compounds as CCR1 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-01 US disclosed
US-20120322790-A1 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-20 US disclosed
WO-2012092168-A1 FUSED 6,5 BICYCLIC RING SYSTEM P2 LIGANDS, AND METHODS FOR TREATING HIV PURDUE RESEARCH FOUNDATION (US) 2012-07-05 WO disclosed
WO-2012092188-A1 HYDROGEN BOND FORMING P1 LIGANDS AND METHODS FOR TREATING HIV GHOSH ARUN K (US) 2012-07-05 WO disclosed
WO-2012087782-A1 PYRAZOLOPIPERIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 WO disclosed
US-20040241706-A1 Highly specific modulators of GTPases for target validation IRM, LLC 2004-12-02 US disclosed
EP-0567015-B1 Method of and apparatus for cleaning oil-deposited material MITSUBISHI CHEM CORP (JP) 1997-11-19 EP disclosed
US-5399203-A Cleaning agent for floating and separation of oil, washing with water and steam MITSUBISHI KASEI CORPORATION (JP) 1995-03-21 US disclosed
EP-0567015-A1 Method of and apparatus for cleaning oil-deposited material and a cleaning agent used therefor Mitsubishi Chemical Corporation (JP) 1993-10-27 EP disclosed